Research Nester recently published report titled “Prostaglandin Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the prostaglandin in terms of market segmentation by type, by product, by end-user and by region.
The global prostaglandin market is segmented on the basis of type into human prostaglandin and veterinary prostaglandin; by product into low purity (97%), purity (>97% and <99%), high purity (99%) and others; by end-user into cardiovascular, digestive and gynecological, ophthalmology and others. The global prostaglandin market is anticipated to record a CAGR of 4.8% over the forecast period i.e. 2019-2027.
Increase in Number of Migraine Patients
The ability of prostaglandin to produce constriction or relaxation of cerebral blood vessels has led to its implication in the pathogenesis of migraine. Prostaglandins may also be implicated for potentiating the effects of bradykinin and other forms of chemically induced pain by sensitizing the peripheral pain receptors. Moreover, it is also considered as the important mediators of the inflammatory response such as edema, erythema and tissue damage and are capable of modulating the release of neuro- transmitters from nerve terminals. Prostaglandin inhibitors are effectively used for shortening the duration of migraine attacks and reduce the side effects such as nausea ,vomiting and abdominal pain. These factors are projected to fuel market growth over the forecast period.
Increase in Number of Cardiovascular Patients
Development in the area of neonatal cardiac surgery has increased the importance of rapid diagnosis and stabilization of infants with CHD. According to WHO report, every year 17.9 million die due to cardiovascular disease which is 31% of total death in one year. With the increasing application of prostaglandin in early stage helps the patients to be more clinically stable for surgery and has also increase the probability of survival after cardiac defect repair. Therapy with prostaglandin can effectively maintain an infant's cardiovascular function until palliative or corrective procedure can be performed. Additionally, the growing geriatric population having major congenital heart disease is expected to boost the market growth over the forecast period.
The main problem with uneven production of prostaglandins is unwanted inflammation in body. Excessive production of prostaglandin can cause chronic disease with pain. Menstruation bleeding, arthritis and some type of cancer are connected to high amount of prostaglandin formation. Sometime, the formation of prostaglandin is not enough to heal the injury. This factor is anticipated to hamper the market over the forecast period.
The market in North America region is expected to display a significant growth owing to increasing number of congenital heart diseases in geriatric population. Further, the Europe market is anticipated to induce a growth on the back of increasing number of increasing number of increasing number of various vascular disease,
The market in Asia Pacific is estimated to highest growth during the forecast period on account of increasing use of prostaglandin in female during pregnancy to relief the labor pain.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
This report also provides the existing competitive scenario of some of the key players of the prostaglandin market which includes company profiling of Abacam, Stemgent, Race Chemical and Anward. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the prostaglandin market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.